Dear everyone
I am currently conducting a nitrosamine risk assessment for finasteride-containing products in accordance with the latest regulatory requirements from EMA, FDA, and ICH M7(R2). As part of this evaluation, I am seeking to gather comprehensive information and reference materials specifically related to N-nitroso-finasteride as a potential nitrosamine drug substance-related impurity (NDSRI).
I would greatly appreciate it if you could share any of the related materials.